vs
Side-by-side financial comparison of Ellington Financial Inc. (EFC) and STEM, INC. (STEM). Click either name above to swap in a different company.
Ellington Financial Inc. is the larger business by last-quarter revenue ($78.2M vs $47.1M, roughly 1.7× STEM, INC.). Ellington Financial Inc. runs the higher net margin — 28.9% vs -33.9%, a 62.8% gap on every dollar of revenue. On growth, Ellington Financial Inc. posted the faster year-over-year revenue change (8.7% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 1.8%).
Ellington Management Group is an American hedge fund firm. As of June 2019, the firm was reportedly managing $8.5 billion in structured products and other credit instruments.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
EFC vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $78.2M | $47.1M |
| Net Profit | $22.6M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | 7.4% | -17.7% |
| Net Margin | 28.9% | -33.9% |
| Revenue YoY | 8.7% | -15.6% |
| Net Profit YoY | -26.2% | 68.8% |
| EPS (diluted) | $0.10 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $78.2M | $47.1M | ||
| Q3 25 | $82.8M | $38.2M | ||
| Q2 25 | $92.5M | $38.4M | ||
| Q1 25 | $82.9M | $32.5M | ||
| Q4 24 | $72.0M | $55.8M | ||
| Q3 24 | $67.0M | $29.3M | ||
| Q2 24 | $91.2M | $34.0M | ||
| Q1 24 | $75.5M | $25.5M |
| Q4 25 | $22.6M | $-16.0M | ||
| Q3 25 | $29.5M | $-23.8M | ||
| Q2 25 | $42.9M | $202.5M | ||
| Q1 25 | $31.6M | $-25.0M | ||
| Q4 24 | $30.7M | $-51.1M | ||
| Q3 24 | $16.2M | $-148.3M | ||
| Q2 24 | $52.3M | $-582.3M | ||
| Q1 24 | $26.9M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | 7.4% | -17.7% | ||
| Q3 25 | 31.1% | -33.6% | ||
| Q2 25 | 38.3% | -34.8% | ||
| Q1 25 | 37.3% | -65.0% | ||
| Q4 24 | 28.0% | -84.4% | ||
| Q3 24 | 24.0% | -493.2% | ||
| Q2 24 | 52.8% | -1705.5% | ||
| Q1 24 | 42.2% | -267.0% |
| Q4 25 | 28.9% | -33.9% | ||
| Q3 25 | 35.7% | -62.2% | ||
| Q2 25 | 46.4% | 527.8% | ||
| Q1 25 | 38.2% | -76.9% | ||
| Q4 24 | 42.6% | -91.6% | ||
| Q3 24 | 24.1% | -506.3% | ||
| Q2 24 | 57.4% | -1712.6% | ||
| Q1 24 | 35.6% | -283.9% |
| Q4 25 | $0.10 | $-4.40 | ||
| Q3 25 | $0.29 | $-2.84 | ||
| Q2 25 | $0.45 | $-1.79 | ||
| Q1 25 | $0.35 | $-0.15 | ||
| Q4 24 | $0.23 | $-15.29 | ||
| Q3 24 | $0.19 | $-18.24 | ||
| Q2 24 | $0.62 | $-71.81 | ||
| Q1 24 | $0.32 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $201.9M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.8B | $-249.4M |
| Total Assets | $19.4B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $201.9M | $48.9M | ||
| Q3 25 | $184.8M | $43.1M | ||
| Q2 25 | $211.0M | $40.8M | ||
| Q1 25 | $203.3M | $58.6M | ||
| Q4 24 | $192.4M | $56.3M | ||
| Q3 24 | $217.7M | $75.4M | ||
| Q2 24 | $198.5M | $89.6M | ||
| Q1 24 | $187.5M | $112.8M |
| Q4 25 | $1.8B | $-249.4M | ||
| Q3 25 | $1.8B | $-235.7M | ||
| Q2 25 | $1.7B | $-214.1M | ||
| Q1 25 | $1.6B | $-417.5M | ||
| Q4 24 | $1.6B | $-398.4M | ||
| Q3 24 | $1.6B | $-344.1M | ||
| Q2 24 | $1.6B | $-203.2M | ||
| Q1 24 | $1.5B | $371.6M |
| Q4 25 | $19.4B | $308.9M | ||
| Q3 25 | $17.8B | $362.6M | ||
| Q2 25 | $17.1B | $379.2M | ||
| Q1 25 | $16.6B | $405.1M | ||
| Q4 24 | $16.3B | $437.4M | ||
| Q3 24 | $16.0B | $537.8M | ||
| Q2 24 | $15.1B | $691.5M | ||
| Q1 24 | $15.1B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-925.5M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -40.92× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-925.5M | $8.2M | ||
| Q3 25 | $-290.4M | $11.4M | ||
| Q2 25 | $-210.5M | $-21.3M | ||
| Q1 25 | $-126.4M | $8.5M | ||
| Q4 24 | $-430.5M | $-14.7M | ||
| Q3 24 | $-141.7M | $-9.4M | ||
| Q2 24 | $-88.6M | $-11.9M | ||
| Q1 24 | $-59.5M | $-621.0K |
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | -40.92× | — | ||
| Q3 25 | -9.84× | — | ||
| Q2 25 | -4.90× | -0.11× | ||
| Q1 25 | -3.99× | — | ||
| Q4 24 | -14.04× | — | ||
| Q3 24 | -8.76× | — | ||
| Q2 24 | -1.69× | — | ||
| Q1 24 | -2.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
